| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/22/1999 | EP0942717A2 Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein |
| 09/22/1999 | EP0804223B1 Hgh containing pharmaceutical compositions |
| 09/22/1999 | EP0726764B1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/22/1999 | CN1229083A Novel phosphononosulfonate compounds and its pharmaceutical compositions |
| 09/21/1999 | US5955617 Also for treatment of impaired glucose tolerance, obesity |
| 09/21/1999 | US5955578 Synthetic matrix of synthetic polypeptide including amino acid sequence of d-arginine-glycine-aspartic acid, a biodegradable polymer, and optional crosslinking agent; temporary wound healing agent which promotes cell migration |
| 09/21/1999 | US5955504 Administering enantiomerically stable antiinflammatory agents/non-steroids/ or a pharmaceutically acceptable salts to treat colon cancer |
| 09/21/1999 | US5955491 Method for treating osteoporosis |
| 09/21/1999 | US5955346 Variants of human prolactin and human placeatal lactogen |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955111 Methods and compositions for inducing production of stress proteins |
| 09/21/1999 | US5955106 Hydrocolloid-forming agent as a retardant |
| 09/21/1999 | CA2127253C Composition to help stop smoking |
| 09/21/1999 | CA2086429C Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol |
| 09/16/1999 | WO1999046575A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/16/1999 | WO1999046367A2 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | WO1999046316A2 Enzyme inhibitors |
| 09/16/1999 | WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | WO1999046272A1 Serine peptidase modulators |
| 09/16/1999 | WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046237A1 Modulators of protein tyrosine phosphatases |
| 09/16/1999 | WO1999045940A1 Method and composition for lowering low density lipoprotein cholesterol |
| 09/16/1999 | WO1999045788A1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 09/16/1999 | WO1999033355A3 Fat blend |
| 09/16/1999 | WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 09/16/1999 | WO1999029321A9 Inhibition of membrane-associated viral replication |
| 09/16/1999 | CA2575850A1 The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
| 09/16/1999 | CA2327329A1 Cholesterol recognition sequence |
| 09/16/1999 | CA2323496A1 Enzyme inhibitors |
| 09/16/1999 | CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | CA2323077A1 Method and composition for lowering low density lipoprotein cholesterol |
| 09/16/1999 | CA2322618A1 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/15/1999 | EP0941733A2 Methods of inhibiting leaderless protein export using cardiac glycosides and derivatives |
| 09/15/1999 | EP0941342A1 Human squalene epoxidase |
| 09/15/1999 | EP0941247A2 Peptide compounds useful for modulating fgf receptor activity |
| 09/15/1999 | EP0941240A1 New picornaviruses, vaccines and diagnostic kits |
| 09/15/1999 | EP0941125A1 Methods for regulating angiogenesis |
| 09/15/1999 | EP0941122A2 Compositions and methods for polynucleotide delivery |
| 09/15/1999 | EP0941114A1 Use of glp-1 peptides |
| 09/15/1999 | EP0941110A1 Uses of keratinocyte growth factor-2 |
| 09/15/1999 | EP0941103A1 Pharmaceutical composition for treatment of diabetes |
| 09/15/1999 | EP0941097A1 Use of mixtures of active substances for the production of hypocholesteremic agents |
| 09/15/1999 | EP0941096A2 A method for lowering plasma levels of lipoprotein(a) |
| 09/15/1999 | EP0941080A2 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 09/15/1999 | EP0741697B1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228770A Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 09/15/1999 | CN1228758A Haphthyl compounds, intermediates, compositions and methods of use |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/15/1999 | CN1228317A Traditional Chinese medicine-Jiangtangwan pill for curing diabets mellitus |
| 09/15/1999 | CN1228272A Haw ice tea drink and its preparing method |
| 09/15/1999 | CN1045088C Purine and guanine compounds as inhibitors of PNP |
| 09/15/1999 | CN1045083C Lifibrol antilipemic agent and its use |
| 09/14/1999 | US5952513 Benzo b! thiophene compounds |
| 09/14/1999 | US5952393 Anticholestereol agent consists of phytosterol and policosanol |
| 09/14/1999 | US5952382 Inhibiting the biological effects of an overregulation of retinoid acid receptors and/or of a hypervitaminosis a; treating skin disorder, eye vision defects, skin aging |
| 09/14/1999 | US5952365 2- 2-(Dimethylamino)ethyl!-8,8-dipropyl-2-azaspiro 4.5!decane dimaleate |
| 09/14/1999 | US5952364 Methods for inhibiting smooth muscle cell proliferation |
| 09/14/1999 | US5952362 2-imidazoline, 2-oxazoline, 2-thiazoline, and 4-imidazole derivatives of methylphenyl, methoxyphenyl, and aminophenyl alkylsulfonamides and ureas and their use |
| 09/14/1999 | US5952356 Treating diabetes in a mammal with an active material and a glucosidase inhibitor |
| 09/14/1999 | US5952354 Enzyme inhibitors of chloesterol ester hydrolase and/or acyl coenzyme a:chloesterol acyltransferase; inhibit the esterification of chloesterol and reduce absorption through the intestine; carbamates of 4-8 membered azacycloalkanols |
| 09/14/1999 | US5952350 Naphthyl compounds and compositions, as estrogen receptor binding agents |
| 09/14/1999 | US5952301 A synergistic mixture of the peptide hormones, glucagon-like peptide-2 (glp-2) and insulin-like growth factor (igf-1,2) or growth hormone to promote the cell growth in the large and small intestines; nutritional, gastrointestinal disorders |
| 09/14/1999 | US5952295 Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract |
| 09/14/1999 | US5950634 Method for assessing oxidative stress and its control in humans |
| 09/14/1999 | CA1340743C Compositions for the treatment of ostoporosis in humans |
| 09/10/1999 | WO1999045135A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
| 09/10/1999 | WO1999045024A1 Cholenic acid amides and pharmaceutical compositions thereof |
| 09/10/1999 | WO1999045016A2 Novel prodrugs for phosphorus-containing compounds |
| 09/10/1999 | WO1999044994A1 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists |
| 09/10/1999 | WO1999044618A1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity |
| 09/10/1999 | WO1999044440A1 Food compositions for preventing periodontosis or preventing the progression of periodontosis and method for preventing or treating periodontosis |
| 09/10/1999 | WO1999021617B1 Allosteric adenosine receptor modulators |
| 09/10/1999 | CA2322425A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
| 09/10/1999 | CA2322207A1 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists |
| 09/08/1999 | EP0940391A2 Quinoline derivatives as tachykinin NK3 receptor antagonists |
| 09/08/1999 | EP0939770A1 Receptor specific brain natriuretic peptide (bnp) |
| 09/08/1999 | EP0939590A1 Delivery of therapeutic gene products by intestinal cell expression |
| 09/08/1999 | EP0871463A4 Regulation of eating behavior |
| 09/08/1999 | EP0589874B1 Use of (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid for the preparation of a longlasting antidiabetic medicament |
| 09/08/1999 | CN1228091A Substituted 6,6-hetero-bicyclic derivatives |
| 09/08/1999 | CN1228025A Hydrosterol composition and use thereof |
| 09/08/1999 | CN1045005C Bisoxadiazolidine derivative, medicinal composition containing same and use thereof |
| 09/07/1999 | US5948810 Use of R-(+)-α-lipoic acid, R-(-)-dihydrolipoic acid and metabolites in the form of the free acid or as salts or esters or amides for the preparation of drugs for the treatment of diabetes mellitus as well as of its sequelae |
| 09/07/1999 | US5948809 (-) cis-6(S)-phenyl-5(R) 4-(2-pyrrolidin-1-yl ethoxy) phenyl!-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrate |
| 09/07/1999 | US5948803 Improve the insulin resistance and have potent hypoglycemic effect and lipid-lowering effect |
| 09/07/1999 | US5948796 Benzo B!thiophene compounds, intermediates, formulations, and methods |
| 09/07/1999 | US5948777 Cannabinoid receptor agonists |
| 09/07/1999 | US5948758 Methods for treating various disease states by reducing adhesion of leukocytes of target cells |
| 09/07/1999 | US5948669 As probes and primers; for diagnosis and treatment of osteoporosis, oral diseases, paget's disease; antiarthritic agents, anticarcinogenic/antitumor/antimetastasis agents |
| 09/07/1999 | US5948442 Nucleoside, low and high molecular weight peptides, activation of biosynthesis of nucleic aics and specific proteins |
| 09/07/1999 | US5948402 Method of using IL-11 for treating antibiotic induced diarrhea |
| 09/07/1999 | CA2014008C Benzimidazoles, medicaments containing these compounds and processes for their preparation |
| 09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | WO1999043813A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 09/02/1999 | WO1999043708A1 Glp-1 derivatives of glp-1 and exendin with protracted profile of action |
| 09/02/1999 | WO1999043707A1 N-terminally modified glp-1 derivatives |